19 July 2021 : Editorial
Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19
DOI: 10.12659/MSM.933973
Med Sci Monit 2021; 27:e933973
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
19 July 2021 : Editorial
DOI: 10.12659/MSM.933973
Med Sci Monit 2021; 27:e933973
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.